$GYHT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.

Page:   1 2 3 4 5 ... 14 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 30 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOGiftG0.0010,0000470,522480.5 K to 470.5 K (-2.08 %)
Nov 27 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS41.2510,000412,500266,711276.7 K to 266.7 K (-3.61 %)
Nov 27 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS41.509,671401,350276,711286.4 K to 276.7 K (-3.38 %)
Nov 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS39.047,889307,955134,800142.7 K to 134.8 K (-5.53 %)
Nov 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS38.244,111157,221142,689146.8 K to 142.7 K (-2.80 %)
Oct 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS30.4312,000365,148146,800158.8 K to 146.8 K (-7.56 %)
Oct 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS30.4312,000365,148146,800158.8 K to 146.8 K (-7.56 %)
Sep 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS26.9112,000322,884158,800170.8 K to 158.8 K (-7.03 %)
Sep 14 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGiftG0.008,0000208,753216.8 K to 208.8 K (-3.69 %)
Sep 14 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorSellS27.0632,000865,792216,753248.8 K to 216.8 K (-12.86 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,884013,766
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF27.702,38065,92611,44213.8 K to 11.4 K (-17.22 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,884013,8226.9 K to 13.8 K (+99.22 %)
Aug 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS28.3012,000339,564170,800182.8 K to 170.8 K (-6.56 %)
Aug 13 2020GYHTHALOZYME THERAPEUT ...Daly James MDirectorSellS29.1234,337999,89331,36565.7 K to 31.4 K (-52.26 %)
Jul 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS29.0112,000348,072182,800194.8 K to 182.8 K (-6.16 %)
May 22 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM7.1418,613132,8970
May 22 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM7.1418,613132,897194,800176.2 K to 194.8 K (+10.56 %)
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM7.1421,387152,70318,613
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS23.8021,387509,075176,187197.6 K to 176.2 K (-10.82 %)
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM7.1421,387152,703197,574176.2 K to 197.6 K (+12.14 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.008,8290123,753114.9 K to 123.8 K (+7.68 %)
May 01 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGrantA0.008,8290248,753239.9 K to 248.8 K (+3.68 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorGrantA0.008,8290286,382277.6 K to 286.4 K (+3.18 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Henderson Jeffrey WilliamDirectorGrantA0.008,829072,10763.3 K to 72.1 K (+13.95 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.008,829065,70256.9 K to 65.7 K (+15.52 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.008,829026,78318 K to 26.8 K (+49.18 %)
May 01 2020GYHTHALOZYME THERAPEUT ...BIZZARI JEAN-PIERREDirectorGrantA0.008,829082,31473.5 K to 82.3 K (+12.01 %)
Apr 03 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0040,796040,796
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.2417,543249,781277,553260 K to 277.6 K (+6.75 %)
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.2517,543249,982260,010242.5 K to 260 K (+7.24 %)
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.1917,543248,933242,467224.9 K to 242.5 K (+7.80 %)
Mar 04 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0048,662048,662
Mar 04 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA20.55104,9692,157,113104,969
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,80308,803
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF21.833,04466,451176,187179.2 K to 176.2 K (-1.70 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,8030179,231170.4 K to 179.2 K (+5.17 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392011,392
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF21.834,50898,410116,167120.7 K to 116.2 K (-3.74 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,3920120,675109.3 K to 120.7 K (+10.42 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,354039,354
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF21.8319,511425,925490,522510 K to 490.5 K (-3.83 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540510,033470.7 K to 510 K (+8.36 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.005,772011,542
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF21.101,99542,095170,428172.4 K to 170.4 K (-1.16 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.005,7720172,423166.7 K to 172.4 K (+3.46 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,730057,458
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF21.1014,244300,548470,679484.9 K to 470.7 K (-2.94 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7300484,923456.2 K to 484.9 K (+6.30 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,130012,387
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF20.001,68133,6206,9388.6 K to 6.9 K (-19.50 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,13008,6194.5 K to 8.6 K (+92.00 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.007,883023,649
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF20.002,72554,500166,651169.4 K to 166.7 K (-1.61 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.007,8830169,376161.5 K to 169.4 K (+4.88 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,26200
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF20.003,89477,880104,174108.1 K to 104.2 K (-3.60 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,2620108,06896.8 K to 108.1 K (+11.63 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0032,795098,384
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF20.0016,259325,180456,193472.5 K to 456.2 K (-3.44 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0032,7950472,452439.7 K to 472.5 K (+7.46 %)
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0025,026025,026
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA19.9853,2111,063,15653,211
Feb 12 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseA0.0032,533032,533
Feb 12 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseA19.9869,1741,382,09769,174
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0032,533032,533
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA19.9869,1741,382,09769,174
Feb 12 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.00125,1260125,126
Feb 12 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA19.98266,0515,315,699266,051
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.0011,55900
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF19.214,28982,392161,493165.8 K to 161.5 K (-2.59 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.0011,5590165,782154.2 K to 165.8 K (+7.49 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0055,48700
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2119,910382,471439,657459.6 K to 439.7 K (-4.33 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0055,4870459,567404.1 K to 459.6 K (+13.73 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.0011,55900
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF19.214,28982,392161,493165.8 K to 161.5 K (-2.59 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.0011,5590165,782154.2 K to 165.8 K (+7.49 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0055,48700
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2119,910382,471439,657459.6 K to 439.7 K (-4.33 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0055,4870459,567404.1 K to 459.6 K (+13.73 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,11900
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF19.218,275158,96396,806105.1 K to 96.8 K (-7.87 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,1190105,08182 K to 105.1 K (+28.21 %)
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...Option ExerciseM0.0020,216060,647
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...Payment of ExerciseF15.466,990108,06513,22620.2 K to 13.2 K (-34.58 %)
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...BuyM0.0020,216020,2160 to 20.2 K
Aug 05 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...SellS16.701,32822,17838,58439.9 K to 38.6 K (-3.33 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.006,87500
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF15.733,40853,60881,96285.4 K to 82 K (-3.99 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.006,875085,37078.5 K to 85.4 K (+8.76 %)
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.002,04304,084
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF14.7570610,41439,91240.6 K to 39.9 K (-1.74 %)
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.002,043040,61838.6 K to 40.6 K (+5.30 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.0012,1730114,924102.8 K to 114.9 K (+11.85 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorGrantA0.0012,1730224,924212.8 K to 224.9 K (+5.72 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.0012,173056,87344.7 K to 56.9 K (+27.23 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.0012,173017,9545.8 K to 18 K (+210.57 %)
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.006,87500
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.542,37739,31666,37368.8 K to 66.4 K (-3.46 %)
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.006,875068,75061.9 K to 68.8 K (+11.11 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.003,88407,767
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.811,34322,57638,57539.9 K to 38.6 K (-3.36 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.003,884039,91836 K to 39.9 K (+10.78 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.0011,392022,784
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.813,93966,21561,87565.8 K to 61.9 K (-5.99 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.0011,392065,81454.4 K to 65.8 K (+20.93 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392022,784
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.813,93966,21578,49582.4 K to 78.5 K (-4.78 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,392082,43471 K to 82.4 K (+16.04 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,354078,708
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.8119,511327,980416,580436.1 K to 416.6 K (-4.47 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540436,091396.7 K to 436.1 K (+9.92 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.006,790020,370
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.542,32238,40636,06738.4 K to 36.1 K (-6.05 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.006,790038,38931.6 K to 38.4 K (+21.49 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.007,809023,425
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.542,70044,65854,42257.1 K to 54.4 K (-4.73 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.007,809057,12249.3 K to 57.1 K (+15.84 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.007,809023,425
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.542,70044,65871,04273.7 K to 71 K (-3.66 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.007,809073,74265.9 K to 73.7 K (+11.84 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,730086,188
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.5414,244235,596396,737411 K to 396.7 K (-3.47 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7300410,981382.3 K to 411 K (+7.52 %)
Feb 14 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0045,046045,046
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA16.6585,9221,430,60185,922
Feb 14 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.00131,1790131,179
Feb 14 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA16.65250,2184,166,130250,218
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0031,25000
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.7314,547243,371382,251396.8 K to 382.3 K (-3.67 %)
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0031,2500396,798365.5 K to 396.8 K (+8.55 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.122,50340,34831,59934.1 K to 31.6 K (-7.34 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.0015,413015,413
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.125,65891,20749,31355 K to 49.3 K (-10.29 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.0015,413054,97139.6 K to 55 K (+38.96 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,119023,119
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.128,317134,07065,93374.3 K to 65.9 K (-11.20 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,119074,25051.1 K to 74.3 K (+45.22 %)
Dec 10 2018GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGiftG0.0015,0000227,751242.8 K to 227.8 K (-6.18 %)
Oct 03 2018GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA0.0080,863080,863
Oct 03 2018GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA18.55149,5162,773,522149,516
Sep 11 2018GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.005,78105,7810 to 5.8 K
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02256,8604,628,6171,897,6102.2 M to 1.9 M (-11.92 %)

Page:   1 2 3 4 5 ... 14 next >